Biological variation of cardiac troponin in stable haemodialysis patients

Annals of Clinical Biochemistry

Volumn 52, Issue 5, 2015, Pages 562-568

  Mbagaya, Wycliffe ^a   Luvai, Ahai ^b   Lopez, Berenice ^c  

^a WESTON GENERAL HOSPITAL   (United Kingdom)

^b Lillyhall Business Centre   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

analytes; cardiology; clinical studies; renal disease; Troponin

Indexed keywords

TROPONIN; BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; BIOLOGICAL VARIATION; BLOOD SAMPLING; CARDIAC TROPONIN 1 CLIA; CLINICAL ARTICLE; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; INDIVIDUALITY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; BLOOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MYOCARDIAL INFARCTION; RENAL REPLACEMENT THERAPY; TRENDS;

AGED; BIOMARKERS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REFERENCE VALUES; RENAL DIALYSIS; TROPONIN I; TROPONIN T;

EID: 84940195839     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563215585877     Document Type: Article

References (36)

1. K.ThygesenJ.S.AlpertA.S.Jaffe. Third universal definition of myocardial infarction. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J2012; 33: 2551–2567.
2. F.S.AppleS.W.SmithL.A.Pearce. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem2008; 54: 723–728.
3. F.S.Apple. A new season for cTn: it's time to keep a scorecard. Clin Chem2009; 55: 1303–1306.
4. E.GiannitsisK.KurzK.Hallermayer. Analytical validation of high-sensitivity cTn T assay. Clin Chem2010; 56: 254–261.
5. A.K.SaengerR.BeyrauS.Braun. Multicentre analytical evaluation of a hs-Tn T assay. Clin Chim Acta2011; 412: 748–754.
6. F.S.AppleM.M.MurakamiL.A.Pearce. Predictive value of cTn I and T for subsequent death in end-stage renal disease. Circulation2002; 106: 2941–2945.
7. C.deFillipeS.L.SeligerW.Kelley. Interpreting CTn from high sensitivity assays with chronic kidney disease without acute coronary syndrome. Clin Chem2012; 58: 1342–1351.
8. N.A.KhanB.R.HemmelgarnM.Tonelli. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation2005; 112: 3088–3096.
9. W.E.KelleyJ.L.JanuzziR.H.Christenson. Increases of cTn in conditions other than acute coronary syndrome and heart failure. Clin Chem2009; 55: 2098–2112.
10. L.H.JacobsJ.van der KerkhofA.M.Mingels. Haemodialysis patients longitudinally assessed by hs-Tn and commercial cTn T and cTn I assays. Ann Clin Biochem2009; 46: 283–290.
11. F.ArtuncC.MuellerT.Breidthardt. Sensitive troponins – which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One2012; 7: e47610.
12. N.KumarM.MichelisM.V.DeVita. Troponin I levels in asymptomatic patients on haemodialysis using a high sensitivity assay. Nephrol Dial Transpl 2010; 26: 665–670.
13. M.WolleyR.StewartE.Curry. Variation in and prognostic importance of troponin T using a high-sensitivity assay in clinically stable haemodialysis patients. Clin Kidney J2013; 64: 402–409.
14. D.MorrowC.CannonR.Jesse. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation2007; 115: e356–e375.
15. A.H.B.WuF.S.AppleA.S.Jaffe. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: use of cTn and the natriuretic peptides for etiologies other than acute coronary syndromes and heart failure. Clin Chem2007; 53: 2086–2096.
16. S.A.HillR.CleveE.Carlisle. Intra-individual variability in troponin T concentration in dialysis patients. Clin Biochem2009; 42: 991–995.
17. D.S.YoungE.K.HarrisE.Cotlove. Biological and analytical components of variation in long-term studies of serum constituents in normal subjects. IV. Results of a study designated to eliminate long-term analytic deviations. Clin Chem1971; 17: 403.
18. C.G.FraserE.K.Harris. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci1989; 27: 409–437.
19. K.M.AakreT.RøraasP.H.Petersen. Week-to-week biological variation in Cardiac Troponin T and Cardiac Troponin I in hemodialysis patients and healthy controls. Clin Chem2014; 60: 838–847.
20. E.M.GowansC.G.Fraser. Biological variation of serum and urine creatinine and creatinine clearance: ramifications for the interpretation of results and patient care. Ann Clin Biochem1988; 25: 259–263.
21. C.G.Fraser. Biological variation: from principles to practice, Washington: AACC Press Washington, 2001, pp. 1–67.
22. N.A.AbbasR.I.JohnM.C.Webb. CTns and renal function in non-dialysis patients with chronic kidney disease. Clin Chem2005; 51: 2056–2066.
23. M.R.FokkemaZ.HermannF.A.Muskiet. Reference change values for brain natriuretic peptides revisited. Clin Chem2006; 52: 1602–1603.
24. T.RoraasP.PetersenS.Sandverg. Confident intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. Clin Chem2012; 58: 1306–1313.
25. M.J.SarnakA.S.Levey. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis2000; 35: S117–S131.
26. G.HafnerB.Thome-KromerJ.Schaube. CTns in serum in chronic renal failure. Clin Chem1994; 40: 1790–1791.
27. D.McGillG.TalulikarJ.M.Potter. Over time, high-sensitivity TNT replaces NT-proBNP as the most powerful predictor of death in dialysis-dependent chronic renal failure. Clin Chim Acta2010; 411: 936–939.
28. A.H.WuQ.A.LuJ.Todd. Short- and long-term biological variation in cTn I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem2009; 55: 52–58.
29. A.H.WuP.AkhigbeF.Wians. Long-term biological variation in cTnI. Clin Biochem2012; 45: 714–716.
30. V.C.VasileA.K.SaengerJ.M.Kroning. Biological and analytical variability of a novel high-sensitivity cTn T assay. Clin Chem2010; 56: 1086–1090.
31. L.FrankensteinA.H.WuK.Hallermayer. Biological variation and reference change value of high sensitivity troponin T in healthy individual during short and intermediate follow-up periods. Clin Chem2011; 57: 1068–1071.
32. A.M.NordenskjoldH.AlhstromK.M.Eggers. Short and long-term individual variation in cTn in patients with stable coronary artery disease. Clin Chem2012; 59: 401–409.
33. C.G.Fraser. Reference change values. Clin Chem Lab Med2012; 50: 807–812.
34. Z.CorteC.GarciaR.Venta. Biological variation of cardiac troponin T in patients with end-stage renal disease and in healthy individuals. Ann Clin Biochem2015; 52: 53–60.
35. M.MuellerM.BienerM.Vafaie. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem2012; 58: 209–218.
36. D.WayandH.BaumG.Schatzle. CTn T and I in end-stage renal failure. Clin Chem2000; 46: 1345–1350.